Access for Life will solve the clinical challenge for patients with chronic disease, that require repetitive vein access with dialysis as our first market. The patented subcutaneously implanted, sensor-enhanced SEAL device preserves vein health while reducing the risk of clinical complications caused by damage to the vessel walls. It provides real-time data collection during hemodialysis. The device provides easy and safe cannulation, enabling patients to self-cannulate at home encouraging home hemodialysis or in the clinic.